Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies

1. Grandal, M.
2. Pernas, B.
3. Tabernilla, A.
4. Mariño, A.
5. Álvarez, H.
6. Valcarce, N.
7. Mena, A.
8. Castro-Iglesias, A.
9. Pérez, A.B.
10. Delgado, M.
11. Poveda, E.